Soloro 7 (Buprenorphine) Patch 5Mg With 4

Category

Analgesics and Anti-inflammatories

Line

Soloro

Brand

Grunenthal

Molecule

Buprenorphine

Presentation

Patch 5 mg With 4

Laboratory

Grunenthal

Indications

Soloro 7 (Buprenorphine) is indicated for the treatment of moderate to severe pain. It is used in patients who require prolonged pain management, as well as in those who have not responded adequately to other analgesics. Buprenorphine acts as a partial opioid receptor agonist, allowing for effective pain control. Additionally, this medication is used in the treatment of opioid dependence as part of a rehabilitation program. It is important to follow medical instructions for its safe and effective use.

Composition

Each Soloro 7 patch contains 5 mg of buprenorphine as the active ingredient. Inactive ingredients include components necessary for the formulation of the transdermal patch, which allow for the controlled release of buprenorphine into the body.

Contraindications

This medication is contraindicated in patients with known hypersensitivity to buprenorphine or any of the excipients in the formulation. It is also contraindicated in patients with severe chronic obstructive pulmonary disease, uncontrolled bronchial asthma, or in those who are being treated with other opioids or who have consumed excessive alcohol.

Precautions

Caution should be exercised in patients with a history of substance abuse, hepatic or renal insufficiency, and in the elderly. Its use should be monitored in patients with respiratory disorders, as well as in those who present a risk of respiratory depression. Its use during pregnancy and lactation is not recommended unless strictly necessary and evaluated by a doctor.

Storage

Store in a cool, dry place, at a temperature not exceeding 30°C. Keep out of reach of children and do not use after the expiration date indicated on the package.

Prescription required for sale.

Consult your doctor.